Nektar Therapeutics
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $6.4M | $55.6M |
| FY2016 | — | $88.1M | $59.6M |
| FY2017 | — | $87.8M | $4.8M |
| FY2018 | — | $1.72B | $194.9M |
| FY2019 | — | $1.41B | $96.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2015 | — | $6.4M | $55.6M |
| FY2016 | — | $88.1M | $59.6M |
| FY2017 | — | $87.8M | $4.8M |
| FY2018 | — | $1.72B | $194.9M |
| FY2019 | — | $1.41B | $96.4M |